The human brain, a complex and enigmatic organ, has long been viewed as a closed system, separate from the body's immune defenses. However, recent research from Stanford challenges this notion, revealing a fascinating and unexpected connection between the brain and the immune system. This discovery not only reshapes our understanding of brain aging but also opens up new avenues for potential treatments for neurological diseases.
The Brain's Immune System: A New Perspective
For decades, scientists believed that the brain's immune cells, known as microglia, were established at birth and remained isolated throughout life. This view, however, is being challenged by a team of researchers led by Julia Belk, a postdoctoral scholar at Stanford Medicine. Their groundbreaking study, published in Nature, reveals that immune cells from elsewhere in the body can enter the human brain as we age.
An Interdisciplinary Journey
Belk's journey into neuroscience began during her graduate studies in Computer Science at Stanford's Humanities and Sciences department. Her interdisciplinary training, which included the Chemistry/Biology Interface Predoctoral Training Program, shaped her unique approach to research, combining basic science, computer science, and medicine. This led to a collaboration with Siddhartha Jaiswal, an associate professor of pathology at Stanford Medicine, and a member of the Institute for Stem Cell Biology and Regenerative Medicine.
Their initial work focused on genetic information from thousands of individuals, revealing that certain clones of immune cells produced by mutated blood stem cells were associated with a reduced risk of Alzheimer's disease. This intriguing finding suggested a potential interaction between these unusual immune cells and the brain.
Challenging Conventional Wisdom
The idea that blood-based immune cells could play a role in Alzheimer's resilience was both unusual and controversial. However, with support from the Knight Initiative for Brain Resilience, the researchers delved deeper into this intriguing possibility. They sought to understand why peripheral immune cells appeared to increase resilience to Alzheimer's and whether they could replenish microglia in the brain.
Tracing the Origins of Immune Cells
To investigate, the team studied human brain tissue, utilizing samples from the Stanford Rapid Autopsy Center and the University of Washington's Alzheimer's Disease Sequencing Project. These programs provided a unique opportunity to compare immune cells in the bloodstream with those in post-mortem brain tissue. The challenge was to trace the origins of immune cells within the brain, and the researchers developed an innovative approach.
By comparing DNA from immune cells in the blood with those in the brain, they used shared mutations as markers of ancestry. Random mutations accumulate in blood stem cells over time, and immune cells inherit these mutations. Thus, matching mutations indicated a shared origin.
A Human-Specific Phenomenon
The results were remarkable. The researchers found that immune cells from the body had indeed entered the brain, and this process began as early as middle age. Furthermore, these peripheral immune cells transformed into specialized microglia, a phenomenon not observed in other species such as mice or non-human primates. This discovery challenges the longstanding view of microglia as a self-sustaining population and suggests a unique aspect of human brain aging.
Implications and Future Directions
Beyond its impact on our understanding of brain immunity, this finding opens up exciting possibilities for brain immunotherapy. Researchers can now explore engineering strategies to harness the potential of peripheral immune cells to target and break down amyloid and tau aggregates associated with neurodegenerative diseases. Additionally, it broadens the scope of research into how the health and history of blood stem cells influence the brain.
As Jaiswal notes, "Our findings suggest that the life history of blood stem cells could influence the risk of brain diseases by altering the microglia."
Belk adds, "This is exciting because it reveals a uniquely human feature of aging that we had no idea about."
This research not only challenges established ideas but also paves the way for innovative approaches to brain health and disease treatment. It is a testament to the power of interdisciplinary collaboration and the potential for groundbreaking discoveries in neuroscience.
